Sector News

Riyadh – Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) logged a 70.68% year-on-year (YoY) jump in net profit to SAR 292.40 million in 2023 from SAR 171.31 million. Revenues grew 20.09% YoY to SAR 1.10 billion last year from …

Riyadh – Mubasher: Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) has appointed Jerome Cabannes as CEO starting 20 February. Cabannes has been serving as Acting CEO since October 2023, previously holding the position …

Riyadh – Mubasher: Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) inked a term sheet with Jiangsu Recbio Technology Company Limited for the licensing, supply, and technology transfer of Recombinant Human …

Riyadh – Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) has secured a short-term revolving banking facility from the Bank of NATIXIS Algeria with a total amount of DZD 1.30 billion (SAR 36.20 million). The loan will support the …

Riyadh – Mubasher: Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) signed sale and purchase agreements (SPAs) to acquire a 68% stake in Swiss-based Osmopharm and exit its 76.40% equity in Egypt-based SPIMACO Misr for …

Riyadh – Mubasher: The board of Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) agreed to provide a corporate guarantee to Al Salam Bank Algeria to back the issuance of a Shariah-compliant short-term revolving banking facility. The …

Riyadh – Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) posted an annual hike of 77.58% in net profit after Zakat and tax to SAR 247.90 million during the first nine months (9M) of 2023, versus SAR 139.60 million. The revenues …

Riyadh – Mubasher: Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) turned profitable at SAR 40.40 million in the first nine months (9M) of 2023, against net losses of SAR 67 million in 9M-22. Revenues amounted to SAR …

Riyadh – Mubasher: The net profits after Zakat and tax of Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) hiked by 81.59% to SAR 170.70 million in the first half (H1) of 2023, versus SAR 94 million in H1-22. Revenues stood at SAR 600.30 …

Riyadh – Mubasher: Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) shifted to net profits after Zakat and tax amounting to SAR 78.80 million in the first half (H1) of 2023. The generated profits were against net losses …

Riyadh – Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) achieved net profits worth SAR 84.40 million during the first quarter (Q1) of 2023, signalling a 94.02% surge from SAR 43.50 million in Q1-22. The earnings per share (EPS) …

Riyadh – Mubasher: The Saudi Exchange (Tadawul) announced that Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) will float its shares on the main market under the symbol 4015 on Tuesday, 20 June. In a bourse filing, Tadawul indicated that …

Riyadh – Mubasher: Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) registered SAR 56.80 million in net profit after Zakat and tax during the first quarter (Q1) of 2023. The recorded net profits were higher by 85.02% …

Riyadh – Mubasher: Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) turned to net losses after Zakat and tax worth SAR 171.20 million in 2022, versus net profits of SAR 18.10 million in 2021. The company generated …

Riyadh – Mubasher: Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) secured two loans worth SAR 900 million with Saudi British Bank (SABB) and Al Rajhi Bank on 28 December 2022. The two facilities are guaranteed by …

Riyadh – Mubasher: The Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) shifted to net losses after Zakat and tax worth SAR 67 million in the first nine months (9M) of 2022. The Tadawul-listed firm’s negative results in …

Riyadh – Mubasher: Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) has inked a SAR 135 million contract with Merck Sharp and Dohme (MSD). The contract covers the signature and renewal licence, supply, and co-marketing …

Riyadh – Mubasher: Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) has secured Sharia-aligned funding at a combined value of SAR 1.26 billion from Bank Albilad, Banque Saudi Fransi, and Gulf International Bank (GIB). …

Riyadh – Mubasher: The Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) has moved to net losses of SAR 21.10 million during the first half (H1) of 2022, against net earnings of SAR 53.63 million in H1-21. Loss per share …

Riyadh – Mubasher: The shareholders of Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) have agreed to distribute a cash dividend of SAR 0.60 per share for 2021. The Saudi listed firm will disburse a total of SAR 72 …

Riyadh – Mubasher: The net profits after Zakat and tax of Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) surged by 25.34% to SAR 30.66 million during the first quarter (Q1) of 2022 from SAR 24.46 million in Q1-21. The …

Riyadh – Mubasher: Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) has appointed Mohammad Talal Al Nahhas as the new Chairman of the board for the coming three years. Moreover, the Saudi listed firm named Ammar …

Riyadh – Mubasher: Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) has posted an annual plunge of 83.47% in net profits after Zakat and tax at SAR 18.10 million in 2021, compared to SAR 109.54 million. Revenues stood …